Addendum to: Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases
Nat Commun
.
2023 Jun 13;14(1):3503.
doi: 10.1038/s41467-023-39141-w.
Authors
Moritz J Schmidt
#
1
,
Ashish Gupta
#
1
,
Christien Bednarski
#
1
,
Stefanie Gehrig-Giannini
1
,
Florian Richter
1
,
Christian Pitzler
1
,
Michael Gamalinda
1
,
Christina Galonska
1
,
Ryo Takeuchi
2
,
Kui Wang
2
,
Caroline Reiss
2
,
Kerstin Dehne
1
,
Michael J Lukason
3
,
Akiko Noma
2
,
Cindy Park-Windhol
2
,
Mariacarmela Allocca
2
,
Albena Kantardzhieva
2
,
Shailendra Sane
2
,
Karolina Kosakowska
2
,
Brian Cafferty
2
,
Jan Tebbe
1
,
Sarah J Spencer
3
,
Scott Munzer
2
,
Christopher J Cheng
2
,
Abraham Scaria
2
,
Andrew M Scharenberg
2
,
André Cohnen
4
,
Wayne M Coco
5
Affiliations
1
Bayer AG, Leverkusen, Germany.
2
Casebia Therapeutics LLC, Cambridge, MA, USA.
3
CRISPR Therapeutics INC, Cambridge, MA, USA.
4
Bayer AG, Leverkusen, Germany. andre.cohnen@bayer.com.
5
Bayer AG, Leverkusen, Germany. wayne.coco@icloud.com.
#
Contributed equally.
PMID:
37311765
PMCID:
PMC10264410
DOI:
10.1038/s41467-023-39141-w
No abstract available
MeSH terms
Clustered Regularly Interspaced Short Palindromic Repeats* / genetics
Gene Editing*
RNA
Substances
RNA